“THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR/CAS9 AS PROSTATE CANCER THERAPY”, JIMKI, vol. 9, no. 1, pp. 23–37, Jul. 2021, doi: 10.53366/jimki.v9i1.321.